Evaluation of management of Graves' disease in District General Hospital: Achievement of consensus guidelines

International Journal of Clinical Practice

Volumn 59, Issue 9, 2005, Pages 1097-1100

  Dasgupta, Sanghamitra ^a,b   Savage, M W ^a  

^a Bury General Hospital   (United Kingdom)

^b ROYAL OLDHAM HOSPITAL   (United Kingdom)

Author keywords

Audit; Graves' disease; Guidelines; Management

Indexed keywords

CARBIMAZOLE; PROPYLTHIOURACIL; RADIOACTIVE IODINE; TECHNETIUM; THYROTROPIN RECEPTOR ANTIBODY; ANTITHYROID AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL PATHWAY; CONSENSUS DEVELOPMENT; CONTROLLED STUDY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GRAVES DISEASE; HOSPITAL CARE; HUMAN; MALE; MEDICAL AUDIT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HOSPITAL; RECURRENCE RISK; REMISSION; THYROID SCINTISCANNING; THYROID SURGERY; THYROTOXICOSIS; GENERAL HOSPITAL; METHODOLOGY; PILOT STUDY; RECURRENT DISEASE;

ANTITHYROID AGENTS; GRAVES DISEASE; GUIDELINE ADHERENCE; HOSPITALS, DISTRICT; HOSPITALS, GENERAL; HUMANS; MEDICAL AUDIT; PILOT PROJECTS; PRACTICE GUIDELINES; RECURRENCE;

EID: 33644835147     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2005.00545.x     Document Type: Article

References (9)

1. Saravanan P, Dayan CM. Thyroid autoantibodies. Endocrinol Metab Clin North Am 2001; 30: 315-37.
2. Weetman AP. Controversy in thyroid disease. J R Coll Physicians Lond 2000; 34: 374-80.
3. Vanderpump MPJ, Ahlquist JAO, Franklyn JA, Clayton RN. Consensus statement for good practice and audit measures in the management of hypothyroidism and hyperthyroidism. Br Med J 1996; 313: 539-44.
4. Takasu N, Oshiro C, Akamine H et al. Thyroid-stimulating antibody and TSH-binding inhibitor immunoglobulin in 277 Graves' patients and in 686 normal subjects. J Endocrinol Invest 1997; 8: 452-61.
5. Takasu N, Yamashiro K, Komiya I, Ochi Y, Sato Y, Nagata A. Remission of Graves hyperthyroidism predicted by smooth decreases of thyroid stimulating antibody and thyrotropin binding inhibitor immunoglobulin during anti thyroid drug treatment. Thyroid 2000; 10: 891-96.
6. Hashizume K, Ichikawa K, Sakurai A et al. Administration of thyroxine in treated Graves' disease. Effects on levels of antibodies to thyroid stimulating hormone receptors and on risk of recurrence of hyperthyroidism. N Engl J Med 1991; 324: 947-53.
7. Bartelena L, Marcocci C, Bogazzi F et al. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. N Engl J Med 1998; 338: 73-78.
8. Perros P. Antithyroid drug treatment before radioiodine in patients with Graves' disease: Soother or menace? Clin Endocrinol 2000; 53: 1-2.
9. Manso PG, Furlanetto RP, Wolosker AM, Paiva ER, de-Abreu MT, Maciel RM. Prospective and controlled study of ophthalmopathy after radioiodine therapy for Graves' hyperthyroidism. Thyroid 1998; 8: 49-52.